InMode Ltd. is a publicly traded global medical technology company headquartered in the United States, recognized for developing and manufacturing innovative energy-based medical devices using radiofrequency (RF), light, and laser technologies. While its core portfolio is widely used in aesthetic medicine, plastic surgery, and dermatology, InMode’s platforms have also been adapted for ophthalmic applications. In eye care, its Envision system applies RF and light-based technologies to deliver advanced, non-invasive treatments for dry eye—particularly Meibomian Gland Dysfunction (MGD)—helping clinicians address underlying ocular surface issues and improve patient comfort and outcomes.